Skip to main navigation

About Us
Centessa Companies
Team
Pipeline
Investors
News
Careers

Investors & Media

Investor Relations

Overview
Press Releases
Events & Publications
Financial Information
Stock Information
Corporate Governance
Shareholder Resources

Events & Presentations

Site - 3rd Tier - Events

Events & Presentations
Publications

Presentations

SerpinPC Phase 2a results in hemophilia A and B

Past Events

Morgan Stanley 19th Annual Global Healthcare Conference

September 14, 2021 5:00 PM EDT

Listen to webcast

SerpinPC Phase 2a results in hemophilia A and B

September 9, 2021 8:30 AM EDT

Listen to webcast

View Presentation 1.1 MB

Goldman Sachs 42nd Annual Global Healthcare Conference

June 8, 2021 5:30 PM EDT

Site - Investor Tools

Print Page
FAQs
Email Alerts
Contact Us
RSS Feeds

Centessa Pharmaceuticals aims to improve R&D productivity by scaling the asset-centric model with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts.

Links

About Us
Centessa Companies
Team
Pipeline
Investors
News
Careers

Investors & Media

Press Releases
Events & Publications
Financial Information
Stock Information
Corporate Governance
Shareholder Resources

Contact Us

info@centessa.com +1.617.468.5770

©2021 Centessa Pharmaceuticals, plc. All Rights Reserved.

Privacy Policy